Don't Get Too Excited About Biogen's Q4 Earnings
January 20, 2017 at 13:20 PM EST
Baird Equity Research expects to see a “less-than-optimal Tecfidera performance” when Biogen Inc (NASDAQ: BIIB) issues its ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.